Vident Investment Advisory’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,205
Closed -$358K 122
2023
Q2
$358K Sell
11,205
-652
-5% -$21.2K 0.01% 807
2023
Q1
$363K Buy
11,857
+3,337
+39% +$132K 0.01% 890
2022
Q4
$333K Buy
8,520
+343
+4% +$15.4K 0.01% 850
2022
Q3
$209K Buy
8,177
+2,629
+47% +$150K 0.01% 987
2022
Q2
$212K Buy
5,548
+723
+15% +$28.7K 0.01% 1113
2022
Q1
$276K Sell
4,825
-335
-6% -$22K 0.01% 1090
2021
Q4
$411K Buy
+5,160
New +$442K 0.01% 981
2021
Q3
Sell
-2,453
Closed -$316K 1162
2021
Q2
$316K Buy
+2,453
New +$195K 0.01% 929

Other funds holding BEAM